FDA To Review Merck's Application To Expand HPV Vaccine Gardasil's Approval To Older Women (Medical News Today)
FDA has granted priority review status to Merck's application to expand marketing of its human papillomavirus vaccine Gardasil to women ages 27 to 45, the company said Wednesday, Reuters reports. The designation means that an FDA decision could come within six months, according to Reuters. currently is approved by the FDA for use by girls and women ages nine to 26 (Reuters, 3/19).

Amgen And Wyeth Announce Updates To U.S. Prescribing Information For Enbrel(R) (Medical News Today)
Amgen (NASDAQ: AMGN) and Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), announced updates to the U.S. Food and Drug Administration (FDA)-approved U.S. Prescribing Information (PI) for Enbrel(R) (etanercept). The U.S.

Pfizer, Glaxo Raise Drug Prices as Prescription Growth Declines (Bloomberg.com)
March 26 (Bloomberg) -- Pfizer Inc. and GlaxoSmithKline Plc , the world's largest drugmakers, are raising prices to boost revenue as prescriptions slow on their best-selling medicines.